Producer
Thermo Fisher Scientific
7
Inputs supplied
3
Goods downstream
0
Facilities
0
Stories
What they make
7 inputs Thermo Fisher Scientific supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
manufactured
FIB-SEM Systems for Semiconductor Inspection →
manufactured
CHO cell culture media →
manufactured
Single-Use Bioreactor Bags (Cellbag) →
chemical
Lipid nanoparticle (LNP) lipid components →
manufactured
Bioprocess Chromatography Resins →
manufactured
Protein A chromatography resin (mAb) →
manufactured
Sterile filtration membrane (0.2 μm) →
Where it shows up
Goods downstream
Essential goods that depend on something Thermo Fisher Scientific makes — pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
Laboratory Products and Biopharma Services
34%Life Sciences Solutions
25%Analytical Instruments
16%Specialty Diagnostics
10%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Did you know2016
Thermo Fisher Scientific — publicly known as the world's largest life sciences supply company (Gibco cell culture, HyPerforma bioreactors, Fisher Scientific lab supplies) — is simultaneously the dominant supplier of FIB-SEM electron microscopes to semiconductor fabs. After acquiring FEI Company in 2016 for $4.2B, Thermo Fisher's Helios FIB-SEM systems became the standard tool for cross-section failure analysis and TEM sample preparation at TSMC, Samsung, Intel, and IMEC. A disruption to Thermo Fisher's Analytical Instruments business would compromise both biopharma manufacturing and advanced semiconductor yield improvement programs.
Thermo Fisher Scientific ↗Capacity2024
Thermo Fisher Analytical Instruments generated approximately $6.8B in 2023 revenue from mass spectrometers, electron microscopes, and chromatography instruments. The Orbitrap mass spectrometer platform (acquired via Finnigan, 2001) holds an estimated 60-70% share of the high-resolution mass spectrometry market used in pharmaceutical quality control and drug discovery. FEI FIB-SEM systems hold approximately 55% share of the semiconductor-grade FIB-SEM market, competing primarily with Hitachi High-Tech and JEOL.
Thermo Fisher Scientific ↗Origin2006
Thermo Fisher's origin as a supply-chain consolidator is itself unusual: the company is the product of the 2006 merger of Thermo Electron (founded 1956, industrial instruments) and Fisher Scientific (founded 1902, lab supply distribution). The combined entity then made over 30 major acquisitions, including Life Technologies ($13.6B, 2014), bringing Gibco and Applied Biosystems brands; FEI Company ($4.2B, 2016), adding electron microscopy; and Patheon ($7.2B, 2017), adding CDMO manufacturing. With ~$43B in 2023 revenue across 125,000 employees in 50+ countries, it is the largest company most scientists interact with daily but few think of as a supply chain risk.
Thermo Fisher Scientific ↗